Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasopressin vs Norepinephrine for Septic Shock in Cancer Patients
NCT01718613Phase 3Completed
- Sponsor
- Instituto do Câncer do Estado de São Paulo
- Start
- Nov 2012
- Primary completion
- Mar 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of vasopressin in septic shock, sponsored by Instituto do Câncer do Estado de São Paulo. Started Nov 2012; status: completed.
02
Drugs
vasopressin
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT01718613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01718613.